Adenocarcinoma of the Lung: Clinical Trials

5 trials for Adenocarcinoma of the Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 21Completed 1

Follow Adenocarcinoma of the Lung: new trials by email Literature Review of Adenocarcinoma of the Lung trials Research Report on Adenocarcinoma of the Lung

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery
gefitinib, placebo, laboratory biomarker analysis - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer
Phase 3CompletedNational Cancer Institute (NCI)5032002-09-012015-01-01
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer
paclitaxel, carboplatin, bevacizumab - Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer
Phase 2 / Phase 3CompletedNational Cancer Institute (NCI)8422002-08-012013-02-27
Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
cisplatin, docetaxel, etoposide - Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer
Phase 3CompletedNational Cancer Institute (NCI)8402001-06-012013-02-27
Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
shark cartilage extract AE-941, placebo, cisplatin - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer
Phase 3CompletedNational Cancer Institute (NCI)7562000-03-012013-01-23
Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer
paclitaxel, carboplatin, therapeutic conventional surgery - Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer
Phase 3CompletedNational Cancer Institute (NCI)5001996-10-012013-07-03

Narrower conditions

Adenocarcinoma of Lung (5)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Adenocarcinoma, Bronchiolo-Alveolar (4)

Broader conditions

Adenocarcinoma (5)  ·  Bronchial Neoplasms (5)  ·  Carcinoma (5)  ·  Carcinoma, Bronchogenic (5)  ·  Lung Diseases (5)  ·  Lung Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms by Site (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Neoplasms (5)  ·  Thoracic Neoplasms (5)

Interventions

Carboplatin (3)  ·  Paclitaxel (3)  ·  Taxes (3)  ·  Cisplatin (2)  ·  Gefitinib (2)  ·  Radiation (2)  ·  Radiotherapy (2)  ·  Bevacizumab (1)  ·  Docetaxel (1)  ·  Etoposide (1)  ·  Vinorelbine (1)  ·  shark cartilage extract (1)

Sponsors

National Cancer Institute (NCI) (5)

Countries

United States (4)  ·  Canada (1)

Top investigators

Alan Sandler (1)  ·  Charles Lu (1)  ·  Gary Strauss (1)  ·  Glennwood Goss (1)  ·  Karen Kelly (1)

Results publications

PMID 17167137

NIH funding

U10CA021115 (1), U10CA031946 (1), U10CA032102 (1), U10CA045809 (1)